The Supreme Cannabis Company, Inc. (T:FIRE*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 178A Ossington Ave
Tel: N/A
IR: See website
Key People
Michael John La Brier
Independent Chairman of the Board
Barinder Singh Bhullar
Vice President - Government Relations and International Affairs
Navdeep S. Dhaliwal
Chief Executive Officer, Director
Nikhil Handa
Chief Financial Officer
Joel Toguri
Senior Vice President, Commercial
Ash Rajendra
Chief Information Officer
Dimitre Naoumov
Vice President - Finance
Craig G.J Young
Vice President of Sales - Canada
Omer Hyder Azeez
Vice President of Marketing and Regulatory Affairs
Steve Chan
Vice President of Investor Relations and Corporate Communications
Business Overview
Supreme Cannabis Company Inc, formerly Supreme Pharmaceuticals Inc, is a Canada-based company. The Company is focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario. The Company's subsidiary is 8528934 Canada Ltd., doing business as 7 ACRES, a licensed producer of medical cannabis. 8528934 Canada Ltd. cultivates medical cannabis at its approximately seven acres (over 342,000 square feet) hybrid greenhouse (the Hybrid Greenhouse) facility in Kincardine, Ontario.
Financial Overview
For the fiscal year ended 30 June 2019, Supreme Cannabis Company Inc revenues increased from C$8.9M to C$41.8M. Net loss increased 97% to C$14.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Wages and benefits increase from C$4.7M to C$13.1M (expense), Finance expense, net increase from C$364K to C$5.2M (expense).
Employees: 750 as of Jun 30, 2019
Reporting Currency: Canadian Dollars
Enterprise value: $339.59M as of Jun 30, 2019
Annual revenue (TTM): $41.83M as of Jun 30, 2019
EBITDA (TTM): -$41.44M as of Jun 30, 2019
Net annual income (TTM): -$14.50M as of Jun 30, 2019
Free cash flow (TTM): -$107.73M as of Jun 30, 2019
Net Debt Last Fiscal Year: $24.23M as of Jun 30, 2019
Shares outstanding: 354,295,204 as of Oct 30, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization